Elisabet Sanchez
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 7
- Oncology top 10%
- PARP inhibition in cancer therapy 4
- Cancer Immunotherapy and Biomarkers 3
- COVID-19 and healthcare impacts 2
- CAR-T cell therapy research 2
-
- Spinal Fractures and Fixation Techniques 2
-
- Renal cell carcinoma treatment 2
-
- Renal and related cancers 2
- Co-authors
- Stergios BoussiosAruni GhoseMatin SheriffElie RassyMichele MoschettaSola AdelekeCyrus ChargariKathrine S Rallis
- Journals
- International Journal of Environmental Research and Public Health (5 papers)Anticancer Research (3 papers)International Journal of Molecular Sciences (3 papers)
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Elisabet Sanchez
17 papers receiving 508 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Reproductive Medicine 194
- Oncology 268
- Cancer Research 102
- Obstetrics and Gynecology 38
- Immunology 67
Countries citing papers authored by Elisabet Sanchez
This map shows the geographic impact of Elisabet Sanchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabet Sanchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabet Sanchez more than expected).
Fields of papers citing papers by Elisabet Sanchez
This network shows the impact of papers produced by Elisabet Sanchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabet Sanchez. The network helps show where Elisabet Sanchez may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Elisabet Sanchez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4breakdown → | 2024 | 52 |
| 5 | 2023 | 29 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 44 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 19 | |
| 11 | 2023 | 17 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 68 | |
| 14 | 2023 | 31 | |
| 15 | 2022 | 76 | |
| 16 | 2022 | 47 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 91 | |
| 19 | 2021 | 12 |
About Elisabet Sanchez
Elisabet Sanchez is a scholar working on Reproductive Medicine, Oncology, Pathology and Forensic Medicine, Oral Surgery and Obstetrics and Gynecology, having authored 19 papers that have together received 512 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Spinal Fractures and Fixation Techniques (2 papers), COVID-19 and healthcare impacts (2 papers), Renal cell carcinoma treatment (2 papers), CAR-T cell therapy research (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Reproductive Medicine (194 citations), Oncology (268 citations), Cancer Research (102 citations), Obstetrics and Gynecology (38 citations) and Immunology (67 citations). Elisabet Sanchez has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Stergios Boussios, Aruni Ghose, Matin Sheriff, Elie Rassy, Michele Moschetta, Sola Adeleke, Cyrus Chargari, Kathrine S Rallis, Christos Mikropoulos and Nicholas Pavlidis. Their work appears in journals such as International Journal of Environmental Research and Public Health, Anticancer Research, International Journal of Molecular Sciences, Cancers and Current Cancer Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.